Contact
Please use this form to send email to PR contact of this press release:
Altimmune Announces Additional Positive Data from Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine
TO:
Please use this form to send email to PR contact of this press release:
Altimmune Announces Additional Positive Data from Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine
TO: